News
-
-
-
-
PRESS RELEASE
PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
PharmaSGP Holding SE's Annual General Meeting approves full profit distribution for 2023 after successful business performance. Peter Gerckens appointed as Chief Commercial Officer -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
PharmaSGP Holding SE proposes a significant increase in dividend to EUR 1.36 per share for 2023, totaling EUR 16,320,000.00. The company plans to adjust its dividend policy for future distributions